ArticleJournal for immunotherapy of cancer2019

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Alexandros Papachristofilou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.